Pharma Excipient Market Size is Estimated to USD 9.81 Billion By...

Pharma Excipient Market Size is Estimated to USD 9.81 Billion By 2032

Posted 2023-12-01 09:13:23

Market Overview: The Pharma Excipient Market achieved a valuation of USD 6.93 billion in 2022 and is projected to reach USD 9.81 billion by 2032, with a Compound Annual Growth Rate (CAGR) of 5.6% during the forecast period. The primary drivers of market revenue growth include increased investments in Research and Development (R&D) activities and the growing demand for innovative drug delivery methods.

Competitive Landscape The pharmaceutical excipient market is highly competitive, with key players such as Dow Chemical Company, BASF SE, Ashland Inc., Kerry Group, Archer Daniels Midland Company, Associated British Foods plc, ABITEC Corporation, Cargill, Inc., Croda International Plc, and FMC Corporation holding a significant market share. The report provides insights into the strategic developments and new product launches by these companies to maintain a competitive edge.

Strategic Developments Several major companies have undertaken strategic developments to strengthen their positions in the pharmaceutical excipient market:

In 2021, BASF SE expanded its production capacity for excipients in Germany to meet the growing demand for pharmaceuticals in the region.
In 2020, Kerry Group acquired Biosearch Life, a Spanish company specializing in natural extracts for the pharmaceutical, nutraceutical, and food industries, aiming to expand its product portfolio in the pharmaceutical excipient market.
In 2020, Ashland Inc. launched a new line of excipients called Plasdone™ S630 Ultra, offering improved disintegration and dissolution properties.
In 2019, Dow Chemical Company launched a new line of excipients called Ethocel™ HP, providing enhanced tablet compression, improved solubility, and increased tablet hardness.

Rising investments in R&D activities by pharmaceutical companies contribute significantly to market expansion, as they focus on developing more efficient and safer medications. Moreover, the demand for pharmaceutical excipients is propelled by the increasing popularity of generic drugs, known for their cost-effectiveness compared to branded pharmaceuticals. Regulatory compliance, governed by entities such as the FDA and EMA, further fuels the need for high-quality excipients adhering to legal standards.

Get a sample copy of the Pharma Excipient Market report: https://www.reportsanddata.com/download-free-sample/2713

Inorganic excipients, contributing to the physicochemical qualities of medicine formulations, are projected to experience substantial growth during the forecast period. The pharmaceutical industry's emphasis on quality and safety is driving the use of inorganic excipients that comply with legal requirements. Co-processed excipients, a blend of organic and inorganic excipients, are utilized in complex pharmacological formulations, addressing challenges such as prolonged release and improved solubility. The demand for co-processed excipients is expected to grow as pharmaceutical companies and academic institutions invest more in R&D activities.

Functionality Overview Pharma excipients, essential for imparting specific capabilities to formulations, are classified into fillers & diluents, binders, disintegrants, lubricants & glidants, flavoring agents & sweeteners, and others. In 2022, the fillers & diluents segment dominated the market in terms of revenue, driven by the need for cost-effective and high-quality medicine formulations. Binders are expected to experience significant growth during the forecast period, playing a crucial role in enhancing the mechanical strength of medication formulations.

Disintegrants, facilitating the dissolution of tablets and capsules in the gastrointestinal tract, are witnessing increased demand for immediate-release formulations with rapid onset and high bioavailability. Lubricants & glidants, employed to reduce friction and enhance the flowability of powders, are expected to grow due to the demand for precise and high-quality medicinal formulations. Flavoring agents & sweeteners are gaining prominence for improving the taste and palatability of medications, especially for patient-centric formulations.

Regional Overview The global pharma excipient market is anticipated to grow at a CAGR of over 6%, with the Asia Pacific region expected to be the largest market. The increasing demand for pharmaceuticals in countries like China and India, driven by the rising prevalence of chronic diseases and an aging population, contributes to the region's growth. China, with its numerous pharmaceutical firms and cost-effective manufacturing capabilities, is projected to dominate the pharmaceutical excipient market in the Asia Pacific.

The North American market is set for considerable expansion, fueled by the adoption of innovative drug delivery technologies and increased R&D activities in the pharmaceutical sector. Europe, with a thriving pharmaceutical industry and stringent regulatory standards, is expected to witness moderate market growth. The region's aging population and the prevalence of chronic diseases will drive the demand for pharmaceuticals and, consequently, pharmaceutical excipients.

New Product Launches Key players have introduced new excipients to meet evolving market demands:

BASF SE launched Kollicoat® MAE 100-55 in 2021, a water-soluble film coating system for immediate and modified-release tablets.
Archer Daniels Midland Company introduced Nutriance™ in 2020, a plant-based excipient with improved solubility and stability.
Cargill, Inc. launched Emultex™ in 2020, a line of excipients for lipid-based drug delivery systems, offering enhanced bioavailability and reduced toxicity.
Croda International Plc introduced SuperRef™ in 2020, a line of excipients for solid-dosage forms with improved tablet compression and disintegration properties.
FMC Corporation launched Aquarius™ in 2020, a water-soluble polymer for immediate and modified-release tablets, providing improved tablet hardness and excellent solubility.

Market Segmentation The report provides a comprehensive market segmentation, covering product types, functionality, formulation types, and regional outlook. Parameters include historical data (2020-2021), base year for estimation (2022), forecast period (2022-2032), and quantitative units (revenue in USD billion). The market size in 2022 was USD 6.93 billion, with a projected revenue of USD 9.81 billion by 2032.

Explore Trending Reports:

Coupling Agents Market-https://www.globenewswire.com/news-release/2019/10/07/1925741/0/en/Coupling-Agents-Market-To-Reach-USD-668-5-Million-By-2026-Reports-And-Data.html

Agricultural Adjuvants Market-https://www.globenewswire.com/news-release/2020/07/01/2056505/0/en/Agricultural-Adjuvants-Market-To-Reach-USD-5-39-Billion-By-2027-Reports-and-Data.html

Butyl Rubber Market-https://www.globenewswire.com/news-release/2020/04/14/2015958/0/en/Butyl-Rubber-Market-To-Reach-USD-6-42-Billion-By-2027-Reports-and-Data.html

Request a customization of the report: https://www.reportsanddata.com/request-customization-form/2713

Thank you for reading our report. To know more about the customization or any query about the report contents, please connect with us and our team will ensure the report is tailored to meet your requirements.

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behaviour shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

John W

(Head of Business Development)

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com

Blogs | Press Release | Industry News | Our competencies

Browse More Upcoming Reports @ https://www.reportsanddata.com/upcoming-reports